BIOMED PHARMACOTHER 润色咨询

BIOMEDICINE & PHARMACOTHERAPY

出版年份:1982 年文章数:8228 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:10.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2172039, encodeId=78e921e2039b3, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:基础article<br>经验分享:经常刷论坛看看大家的新进展,总想着接收了来分享自己的流程,每天刷新系统,终于等来了accept,流程具体时间记不清楚了,大致回忆下:<br>8月底投稿<br>20天后with editor<br>2天后under review<br>10月初开始陆续回来外审意见,邀请了9个审稿人,3个审稿人接受审稿,审稿意见那是一个真刁钻,都是送命题,要求大修,感觉部分审稿人就存在偏见,没办法,谁让他们是审稿人呢,只能按要求办了。<br>天天熬夜补实验,然后润色,1个多月后修回,编辑那里效率很高,当天就with editor,第二天再次送审<br>11天后accept<br>注:投稿的时候上传了所有原始数据,WB的图全是整膜,也上传了路线图,所以编辑那里过得快,没再补什么;感觉最近接收了好多综述,现在投稿的人太多了,14天很难处理得过来,后边的时间就会延长,送审了过后邮件会有链接追溯文章的状态,还可以用**订阅。接收后邮件里也有链接让确认,然后就是缴费,可以用支付宝、**直接支付,方便了很多,支付了再给Invoice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a52b5395228, createdName=ms3000001076220736, createdTime=Thu Nov 30 10:30:33 CST 2023, time=2023-11-30, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2195921, encodeId=139a219592122, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/0e14153e72354362b59e8a071c515255-bF5cocj4dNVm.png, type=image, width=781, height=315)], authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Thu Mar 28 19:40:17 CST 2024, time=2小时前, status=0, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2185142, encodeId=63162185142c0, content=多久有人愿意审稿呀。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Wed Jan 31 23:23:06 CST 2024, time=2024-01-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189500, encodeId=7ef62189500b2, content=偏重的研究方向:肿瘤<br>经验分享:年前投稿的,昨天送审,1000+号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4019047506, createdName=ms2000001254072347, createdTime=Mon Feb 26 19:11:05 CST 2024, time=2024-02-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192087, encodeId=2e7d219208ead, content=记录一下,2.16投稿的,1300+,今天还是Submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aa0b5490731, createdName=chy, createdTime=Fri Mar 08 14:54:38 CST 2024, time=2024-03-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2175017, encodeId=05c721e5017e2, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;综述<br>经验分享:66**号,第二次投稿(8月初第一次没找到审稿人,一个月拒了,说欢迎修改题目和关键词后重投),第二次投稿邀请了25个人,终于找到了一个审稿人愿意审稿,小修了2次(相当于这个审稿人审了3次文章),每次都是审10天左右,然后等编辑5天左右做决定,也就是一次修稿周期就得20天,今天终于接收了。9月18号投的稿。 送审之后修回的概率很大,对大而不精的综述特别友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/36e4b1345247d92b63b923885e50e463.jpg, createdBy=921d5250503, createdName=147ddcd3m55暂无昵称, createdTime=Fri Dec 15 01:05:53 CST 2023, time=2023-12-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192558, encodeId=95eb21925583c, content=记录一下,2月22日投稿,1600+,还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f7f5535320, createdName=ms3000000361924578, createdTime=Mon Mar 11 14:09:31 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2185510, encodeId=c458218551089, content=偏重的研究方向:心血管<br>经验分享:2023年12月8 Submitted<br>2024年1月15 with editor<br>2024年1月30 Under Review<br>还要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98188622439, createdName=ms3000001775227501, createdTime=Fri Feb 02 15:09:20 CST 2024, time=2024-02-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2193046, encodeId=494b21930461d, content=偏重的研究方向:肿瘤;综述<br>经验分享:为啥找不到审稿人呢<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4019047506, createdName=ms2000001254072347, createdTime=Wed Mar 13 20:37:05 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194188, encodeId=3695219418871, content=好像最近没有中国人的论著文章发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0ea8286723, createdName=ms3000000851999119, createdTime=Tue Mar 19 23:26:22 CST 2024, time=2024-03-19, status=1, ipAttribution=弗吉尼亚)]
    2023-11-30 ms3000001076220736 来自湖北省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:基础article
    经验分享:经常刷论坛看看大家的新进展,总想着接收了来分享自己的流程,每天刷新系统,终于等来了accept,流程具体时间记不清楚了,大致回忆下:
    8月底投稿
    20天后with editor
    2天后under review
    10月初开始陆续回来外审意见,邀请了9个审稿人,3个审稿人接受审稿,审稿意见那是一个真刁钻,都是送命题,要求大修,感觉部分审稿人就存在偏见,没办法,谁让他们是审稿人呢,只能按要求办了。
    天天熬夜补实验,然后润色,1个多月后修回,编辑那里效率很高,当天就with editor,第二天再次送审
    11天后accept
    注:投稿的时候上传了所有原始数据,WB的图全是整膜,也上传了路线图,所以编辑那里过得快,没再补什么;感觉最近接收了好多综述,现在投稿的人太多了,14天很难处理得过来,后边的时间就会延长,送审了过后邮件会有链接追溯文章的状态,还可以用**订阅。接收后邮件里也有链接让确认,然后就是缴费,可以用支付宝、**直接支付,方便了很多,支付了再给Invoice

    11

    展开11条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2172039, encodeId=78e921e2039b3, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:基础article<br>经验分享:经常刷论坛看看大家的新进展,总想着接收了来分享自己的流程,每天刷新系统,终于等来了accept,流程具体时间记不清楚了,大致回忆下:<br>8月底投稿<br>20天后with editor<br>2天后under review<br>10月初开始陆续回来外审意见,邀请了9个审稿人,3个审稿人接受审稿,审稿意见那是一个真刁钻,都是送命题,要求大修,感觉部分审稿人就存在偏见,没办法,谁让他们是审稿人呢,只能按要求办了。<br>天天熬夜补实验,然后润色,1个多月后修回,编辑那里效率很高,当天就with editor,第二天再次送审<br>11天后accept<br>注:投稿的时候上传了所有原始数据,WB的图全是整膜,也上传了路线图,所以编辑那里过得快,没再补什么;感觉最近接收了好多综述,现在投稿的人太多了,14天很难处理得过来,后边的时间就会延长,送审了过后邮件会有链接追溯文章的状态,还可以用**订阅。接收后邮件里也有链接让确认,然后就是缴费,可以用支付宝、**直接支付,方便了很多,支付了再给Invoice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a52b5395228, createdName=ms3000001076220736, createdTime=Thu Nov 30 10:30:33 CST 2023, time=2023-11-30, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2195921, encodeId=139a219592122, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/0e14153e72354362b59e8a071c515255-bF5cocj4dNVm.png, type=image, width=781, height=315)], authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Thu Mar 28 19:40:17 CST 2024, time=2小时前, status=0, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2185142, encodeId=63162185142c0, content=多久有人愿意审稿呀。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Wed Jan 31 23:23:06 CST 2024, time=2024-01-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189500, encodeId=7ef62189500b2, content=偏重的研究方向:肿瘤<br>经验分享:年前投稿的,昨天送审,1000+号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4019047506, createdName=ms2000001254072347, createdTime=Mon Feb 26 19:11:05 CST 2024, time=2024-02-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192087, encodeId=2e7d219208ead, content=记录一下,2.16投稿的,1300+,今天还是Submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aa0b5490731, createdName=chy, createdTime=Fri Mar 08 14:54:38 CST 2024, time=2024-03-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2175017, encodeId=05c721e5017e2, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;综述<br>经验分享:66**号,第二次投稿(8月初第一次没找到审稿人,一个月拒了,说欢迎修改题目和关键词后重投),第二次投稿邀请了25个人,终于找到了一个审稿人愿意审稿,小修了2次(相当于这个审稿人审了3次文章),每次都是审10天左右,然后等编辑5天左右做决定,也就是一次修稿周期就得20天,今天终于接收了。9月18号投的稿。 送审之后修回的概率很大,对大而不精的综述特别友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/36e4b1345247d92b63b923885e50e463.jpg, createdBy=921d5250503, createdName=147ddcd3m55暂无昵称, createdTime=Fri Dec 15 01:05:53 CST 2023, time=2023-12-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192558, encodeId=95eb21925583c, content=记录一下,2月22日投稿,1600+,还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f7f5535320, createdName=ms3000000361924578, createdTime=Mon Mar 11 14:09:31 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2185510, encodeId=c458218551089, content=偏重的研究方向:心血管<br>经验分享:2023年12月8 Submitted<br>2024年1月15 with editor<br>2024年1月30 Under Review<br>还要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98188622439, createdName=ms3000001775227501, createdTime=Fri Feb 02 15:09:20 CST 2024, time=2024-02-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2193046, encodeId=494b21930461d, content=偏重的研究方向:肿瘤;综述<br>经验分享:为啥找不到审稿人呢<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4019047506, createdName=ms2000001254072347, createdTime=Wed Mar 13 20:37:05 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194188, encodeId=3695219418871, content=好像最近没有中国人的论著文章发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0ea8286723, createdName=ms3000000851999119, createdTime=Tue Mar 19 23:26:22 CST 2024, time=2024-03-19, status=1, ipAttribution=弗吉尼亚)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2172039, encodeId=78e921e2039b3, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:基础article<br>经验分享:经常刷论坛看看大家的新进展,总想着接收了来分享自己的流程,每天刷新系统,终于等来了accept,流程具体时间记不清楚了,大致回忆下:<br>8月底投稿<br>20天后with editor<br>2天后under review<br>10月初开始陆续回来外审意见,邀请了9个审稿人,3个审稿人接受审稿,审稿意见那是一个真刁钻,都是送命题,要求大修,感觉部分审稿人就存在偏见,没办法,谁让他们是审稿人呢,只能按要求办了。<br>天天熬夜补实验,然后润色,1个多月后修回,编辑那里效率很高,当天就with editor,第二天再次送审<br>11天后accept<br>注:投稿的时候上传了所有原始数据,WB的图全是整膜,也上传了路线图,所以编辑那里过得快,没再补什么;感觉最近接收了好多综述,现在投稿的人太多了,14天很难处理得过来,后边的时间就会延长,送审了过后邮件会有链接追溯文章的状态,还可以用**订阅。接收后邮件里也有链接让确认,然后就是缴费,可以用支付宝、**直接支付,方便了很多,支付了再给Invoice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a52b5395228, createdName=ms3000001076220736, createdTime=Thu Nov 30 10:30:33 CST 2023, time=2023-11-30, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2195921, encodeId=139a219592122, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/0e14153e72354362b59e8a071c515255-bF5cocj4dNVm.png, type=image, width=781, height=315)], authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Thu Mar 28 19:40:17 CST 2024, time=2小时前, status=0, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2185142, encodeId=63162185142c0, content=多久有人愿意审稿呀。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Wed Jan 31 23:23:06 CST 2024, time=2024-01-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189500, encodeId=7ef62189500b2, content=偏重的研究方向:肿瘤<br>经验分享:年前投稿的,昨天送审,1000+号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4019047506, createdName=ms2000001254072347, createdTime=Mon Feb 26 19:11:05 CST 2024, time=2024-02-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192087, encodeId=2e7d219208ead, content=记录一下,2.16投稿的,1300+,今天还是Submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aa0b5490731, createdName=chy, createdTime=Fri Mar 08 14:54:38 CST 2024, time=2024-03-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2175017, encodeId=05c721e5017e2, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;综述<br>经验分享:66**号,第二次投稿(8月初第一次没找到审稿人,一个月拒了,说欢迎修改题目和关键词后重投),第二次投稿邀请了25个人,终于找到了一个审稿人愿意审稿,小修了2次(相当于这个审稿人审了3次文章),每次都是审10天左右,然后等编辑5天左右做决定,也就是一次修稿周期就得20天,今天终于接收了。9月18号投的稿。 送审之后修回的概率很大,对大而不精的综述特别友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/36e4b1345247d92b63b923885e50e463.jpg, createdBy=921d5250503, createdName=147ddcd3m55暂无昵称, createdTime=Fri Dec 15 01:05:53 CST 2023, time=2023-12-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192558, encodeId=95eb21925583c, content=记录一下,2月22日投稿,1600+,还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f7f5535320, createdName=ms3000000361924578, createdTime=Mon Mar 11 14:09:31 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2185510, encodeId=c458218551089, content=偏重的研究方向:心血管<br>经验分享:2023年12月8 Submitted<br>2024年1月15 with editor<br>2024年1月30 Under Review<br>还要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98188622439, createdName=ms3000001775227501, createdTime=Fri Feb 02 15:09:20 CST 2024, time=2024-02-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2193046, encodeId=494b21930461d, content=偏重的研究方向:肿瘤;综述<br>经验分享:为啥找不到审稿人呢<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4019047506, createdName=ms2000001254072347, createdTime=Wed Mar 13 20:37:05 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194188, encodeId=3695219418871, content=好像最近没有中国人的论著文章发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0ea8286723, createdName=ms3000000851999119, createdTime=Tue Mar 19 23:26:22 CST 2024, time=2024-03-19, status=1, ipAttribution=弗吉尼亚)]
    2024-01-31 ms8000001441772842 来自北京

    多久有人愿意审稿呀。

    4

    展开4条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2172039, encodeId=78e921e2039b3, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:基础article<br>经验分享:经常刷论坛看看大家的新进展,总想着接收了来分享自己的流程,每天刷新系统,终于等来了accept,流程具体时间记不清楚了,大致回忆下:<br>8月底投稿<br>20天后with editor<br>2天后under review<br>10月初开始陆续回来外审意见,邀请了9个审稿人,3个审稿人接受审稿,审稿意见那是一个真刁钻,都是送命题,要求大修,感觉部分审稿人就存在偏见,没办法,谁让他们是审稿人呢,只能按要求办了。<br>天天熬夜补实验,然后润色,1个多月后修回,编辑那里效率很高,当天就with editor,第二天再次送审<br>11天后accept<br>注:投稿的时候上传了所有原始数据,WB的图全是整膜,也上传了路线图,所以编辑那里过得快,没再补什么;感觉最近接收了好多综述,现在投稿的人太多了,14天很难处理得过来,后边的时间就会延长,送审了过后邮件会有链接追溯文章的状态,还可以用**订阅。接收后邮件里也有链接让确认,然后就是缴费,可以用支付宝、**直接支付,方便了很多,支付了再给Invoice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a52b5395228, createdName=ms3000001076220736, createdTime=Thu Nov 30 10:30:33 CST 2023, time=2023-11-30, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2195921, encodeId=139a219592122, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/0e14153e72354362b59e8a071c515255-bF5cocj4dNVm.png, type=image, width=781, height=315)], authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Thu Mar 28 19:40:17 CST 2024, time=2小时前, status=0, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2185142, encodeId=63162185142c0, content=多久有人愿意审稿呀。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Wed Jan 31 23:23:06 CST 2024, time=2024-01-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189500, encodeId=7ef62189500b2, content=偏重的研究方向:肿瘤<br>经验分享:年前投稿的,昨天送审,1000+号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4019047506, createdName=ms2000001254072347, createdTime=Mon Feb 26 19:11:05 CST 2024, time=2024-02-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192087, encodeId=2e7d219208ead, content=记录一下,2.16投稿的,1300+,今天还是Submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aa0b5490731, createdName=chy, createdTime=Fri Mar 08 14:54:38 CST 2024, time=2024-03-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2175017, encodeId=05c721e5017e2, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;综述<br>经验分享:66**号,第二次投稿(8月初第一次没找到审稿人,一个月拒了,说欢迎修改题目和关键词后重投),第二次投稿邀请了25个人,终于找到了一个审稿人愿意审稿,小修了2次(相当于这个审稿人审了3次文章),每次都是审10天左右,然后等编辑5天左右做决定,也就是一次修稿周期就得20天,今天终于接收了。9月18号投的稿。 送审之后修回的概率很大,对大而不精的综述特别友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/36e4b1345247d92b63b923885e50e463.jpg, createdBy=921d5250503, createdName=147ddcd3m55暂无昵称, createdTime=Fri Dec 15 01:05:53 CST 2023, time=2023-12-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192558, encodeId=95eb21925583c, content=记录一下,2月22日投稿,1600+,还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f7f5535320, createdName=ms3000000361924578, createdTime=Mon Mar 11 14:09:31 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2185510, encodeId=c458218551089, content=偏重的研究方向:心血管<br>经验分享:2023年12月8 Submitted<br>2024年1月15 with editor<br>2024年1月30 Under Review<br>还要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98188622439, createdName=ms3000001775227501, createdTime=Fri Feb 02 15:09:20 CST 2024, time=2024-02-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2193046, encodeId=494b21930461d, content=偏重的研究方向:肿瘤;综述<br>经验分享:为啥找不到审稿人呢<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4019047506, createdName=ms2000001254072347, createdTime=Wed Mar 13 20:37:05 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194188, encodeId=3695219418871, content=好像最近没有中国人的论著文章发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0ea8286723, createdName=ms3000000851999119, createdTime=Tue Mar 19 23:26:22 CST 2024, time=2024-03-19, status=1, ipAttribution=弗吉尼亚)]
    2024-02-26 ms2000001254072347 来自四川省

    偏重的研究方向:肿瘤
    经验分享:年前投稿的,昨天送审,1000+号

    14

    展开14条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2172039, encodeId=78e921e2039b3, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:基础article<br>经验分享:经常刷论坛看看大家的新进展,总想着接收了来分享自己的流程,每天刷新系统,终于等来了accept,流程具体时间记不清楚了,大致回忆下:<br>8月底投稿<br>20天后with editor<br>2天后under review<br>10月初开始陆续回来外审意见,邀请了9个审稿人,3个审稿人接受审稿,审稿意见那是一个真刁钻,都是送命题,要求大修,感觉部分审稿人就存在偏见,没办法,谁让他们是审稿人呢,只能按要求办了。<br>天天熬夜补实验,然后润色,1个多月后修回,编辑那里效率很高,当天就with editor,第二天再次送审<br>11天后accept<br>注:投稿的时候上传了所有原始数据,WB的图全是整膜,也上传了路线图,所以编辑那里过得快,没再补什么;感觉最近接收了好多综述,现在投稿的人太多了,14天很难处理得过来,后边的时间就会延长,送审了过后邮件会有链接追溯文章的状态,还可以用**订阅。接收后邮件里也有链接让确认,然后就是缴费,可以用支付宝、**直接支付,方便了很多,支付了再给Invoice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a52b5395228, createdName=ms3000001076220736, createdTime=Thu Nov 30 10:30:33 CST 2023, time=2023-11-30, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2195921, encodeId=139a219592122, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/0e14153e72354362b59e8a071c515255-bF5cocj4dNVm.png, type=image, width=781, height=315)], authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Thu Mar 28 19:40:17 CST 2024, time=2小时前, status=0, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2185142, encodeId=63162185142c0, content=多久有人愿意审稿呀。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Wed Jan 31 23:23:06 CST 2024, time=2024-01-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189500, encodeId=7ef62189500b2, content=偏重的研究方向:肿瘤<br>经验分享:年前投稿的,昨天送审,1000+号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4019047506, createdName=ms2000001254072347, createdTime=Mon Feb 26 19:11:05 CST 2024, time=2024-02-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192087, encodeId=2e7d219208ead, content=记录一下,2.16投稿的,1300+,今天还是Submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aa0b5490731, createdName=chy, createdTime=Fri Mar 08 14:54:38 CST 2024, time=2024-03-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2175017, encodeId=05c721e5017e2, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;综述<br>经验分享:66**号,第二次投稿(8月初第一次没找到审稿人,一个月拒了,说欢迎修改题目和关键词后重投),第二次投稿邀请了25个人,终于找到了一个审稿人愿意审稿,小修了2次(相当于这个审稿人审了3次文章),每次都是审10天左右,然后等编辑5天左右做决定,也就是一次修稿周期就得20天,今天终于接收了。9月18号投的稿。 送审之后修回的概率很大,对大而不精的综述特别友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/36e4b1345247d92b63b923885e50e463.jpg, createdBy=921d5250503, createdName=147ddcd3m55暂无昵称, createdTime=Fri Dec 15 01:05:53 CST 2023, time=2023-12-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192558, encodeId=95eb21925583c, content=记录一下,2月22日投稿,1600+,还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f7f5535320, createdName=ms3000000361924578, createdTime=Mon Mar 11 14:09:31 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2185510, encodeId=c458218551089, content=偏重的研究方向:心血管<br>经验分享:2023年12月8 Submitted<br>2024年1月15 with editor<br>2024年1月30 Under Review<br>还要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98188622439, createdName=ms3000001775227501, createdTime=Fri Feb 02 15:09:20 CST 2024, time=2024-02-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2193046, encodeId=494b21930461d, content=偏重的研究方向:肿瘤;综述<br>经验分享:为啥找不到审稿人呢<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4019047506, createdName=ms2000001254072347, createdTime=Wed Mar 13 20:37:05 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194188, encodeId=3695219418871, content=好像最近没有中国人的论著文章发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0ea8286723, createdName=ms3000000851999119, createdTime=Tue Mar 19 23:26:22 CST 2024, time=2024-03-19, status=1, ipAttribution=弗吉尼亚)]
    2024-03-08 chy 来自辽宁省

    记录一下,2.16投稿的,1300+,今天还是Submitted to journal

    10

    展开10条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2172039, encodeId=78e921e2039b3, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:基础article<br>经验分享:经常刷论坛看看大家的新进展,总想着接收了来分享自己的流程,每天刷新系统,终于等来了accept,流程具体时间记不清楚了,大致回忆下:<br>8月底投稿<br>20天后with editor<br>2天后under review<br>10月初开始陆续回来外审意见,邀请了9个审稿人,3个审稿人接受审稿,审稿意见那是一个真刁钻,都是送命题,要求大修,感觉部分审稿人就存在偏见,没办法,谁让他们是审稿人呢,只能按要求办了。<br>天天熬夜补实验,然后润色,1个多月后修回,编辑那里效率很高,当天就with editor,第二天再次送审<br>11天后accept<br>注:投稿的时候上传了所有原始数据,WB的图全是整膜,也上传了路线图,所以编辑那里过得快,没再补什么;感觉最近接收了好多综述,现在投稿的人太多了,14天很难处理得过来,后边的时间就会延长,送审了过后邮件会有链接追溯文章的状态,还可以用**订阅。接收后邮件里也有链接让确认,然后就是缴费,可以用支付宝、**直接支付,方便了很多,支付了再给Invoice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a52b5395228, createdName=ms3000001076220736, createdTime=Thu Nov 30 10:30:33 CST 2023, time=2023-11-30, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2195921, encodeId=139a219592122, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/0e14153e72354362b59e8a071c515255-bF5cocj4dNVm.png, type=image, width=781, height=315)], authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Thu Mar 28 19:40:17 CST 2024, time=2小时前, status=0, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2185142, encodeId=63162185142c0, content=多久有人愿意审稿呀。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Wed Jan 31 23:23:06 CST 2024, time=2024-01-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189500, encodeId=7ef62189500b2, content=偏重的研究方向:肿瘤<br>经验分享:年前投稿的,昨天送审,1000+号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4019047506, createdName=ms2000001254072347, createdTime=Mon Feb 26 19:11:05 CST 2024, time=2024-02-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192087, encodeId=2e7d219208ead, content=记录一下,2.16投稿的,1300+,今天还是Submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aa0b5490731, createdName=chy, createdTime=Fri Mar 08 14:54:38 CST 2024, time=2024-03-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2175017, encodeId=05c721e5017e2, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;综述<br>经验分享:66**号,第二次投稿(8月初第一次没找到审稿人,一个月拒了,说欢迎修改题目和关键词后重投),第二次投稿邀请了25个人,终于找到了一个审稿人愿意审稿,小修了2次(相当于这个审稿人审了3次文章),每次都是审10天左右,然后等编辑5天左右做决定,也就是一次修稿周期就得20天,今天终于接收了。9月18号投的稿。 送审之后修回的概率很大,对大而不精的综述特别友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/36e4b1345247d92b63b923885e50e463.jpg, createdBy=921d5250503, createdName=147ddcd3m55暂无昵称, createdTime=Fri Dec 15 01:05:53 CST 2023, time=2023-12-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192558, encodeId=95eb21925583c, content=记录一下,2月22日投稿,1600+,还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f7f5535320, createdName=ms3000000361924578, createdTime=Mon Mar 11 14:09:31 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2185510, encodeId=c458218551089, content=偏重的研究方向:心血管<br>经验分享:2023年12月8 Submitted<br>2024年1月15 with editor<br>2024年1月30 Under Review<br>还要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98188622439, createdName=ms3000001775227501, createdTime=Fri Feb 02 15:09:20 CST 2024, time=2024-02-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2193046, encodeId=494b21930461d, content=偏重的研究方向:肿瘤;综述<br>经验分享:为啥找不到审稿人呢<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4019047506, createdName=ms2000001254072347, createdTime=Wed Mar 13 20:37:05 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194188, encodeId=3695219418871, content=好像最近没有中国人的论著文章发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0ea8286723, createdName=ms3000000851999119, createdTime=Tue Mar 19 23:26:22 CST 2024, time=2024-03-19, status=1, ipAttribution=弗吉尼亚)]
    2023-12-15 147ddcd3m55暂无昵称 来自北京

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向:肿瘤;综述
    经验分享:66**号,第二次投稿(8月初第一次没找到审稿人,一个月拒了,说欢迎修改题目和关键词后重投),第二次投稿邀请了25个人,终于找到了一个审稿人愿意审稿,小修了2次(相当于这个审稿人审了3次文章),每次都是审10天左右,然后等编辑5天左右做决定,也就是一次修稿周期就得20天,今天终于接收了。9月18号投的稿。 送审之后修回的概率很大,对大而不精的综述特别友好。

    8

    展开8条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2172039, encodeId=78e921e2039b3, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:基础article<br>经验分享:经常刷论坛看看大家的新进展,总想着接收了来分享自己的流程,每天刷新系统,终于等来了accept,流程具体时间记不清楚了,大致回忆下:<br>8月底投稿<br>20天后with editor<br>2天后under review<br>10月初开始陆续回来外审意见,邀请了9个审稿人,3个审稿人接受审稿,审稿意见那是一个真刁钻,都是送命题,要求大修,感觉部分审稿人就存在偏见,没办法,谁让他们是审稿人呢,只能按要求办了。<br>天天熬夜补实验,然后润色,1个多月后修回,编辑那里效率很高,当天就with editor,第二天再次送审<br>11天后accept<br>注:投稿的时候上传了所有原始数据,WB的图全是整膜,也上传了路线图,所以编辑那里过得快,没再补什么;感觉最近接收了好多综述,现在投稿的人太多了,14天很难处理得过来,后边的时间就会延长,送审了过后邮件会有链接追溯文章的状态,还可以用**订阅。接收后邮件里也有链接让确认,然后就是缴费,可以用支付宝、**直接支付,方便了很多,支付了再给Invoice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a52b5395228, createdName=ms3000001076220736, createdTime=Thu Nov 30 10:30:33 CST 2023, time=2023-11-30, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2195921, encodeId=139a219592122, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/0e14153e72354362b59e8a071c515255-bF5cocj4dNVm.png, type=image, width=781, height=315)], authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Thu Mar 28 19:40:17 CST 2024, time=2小时前, status=0, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2185142, encodeId=63162185142c0, content=多久有人愿意审稿呀。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Wed Jan 31 23:23:06 CST 2024, time=2024-01-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189500, encodeId=7ef62189500b2, content=偏重的研究方向:肿瘤<br>经验分享:年前投稿的,昨天送审,1000+号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4019047506, createdName=ms2000001254072347, createdTime=Mon Feb 26 19:11:05 CST 2024, time=2024-02-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192087, encodeId=2e7d219208ead, content=记录一下,2.16投稿的,1300+,今天还是Submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aa0b5490731, createdName=chy, createdTime=Fri Mar 08 14:54:38 CST 2024, time=2024-03-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2175017, encodeId=05c721e5017e2, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;综述<br>经验分享:66**号,第二次投稿(8月初第一次没找到审稿人,一个月拒了,说欢迎修改题目和关键词后重投),第二次投稿邀请了25个人,终于找到了一个审稿人愿意审稿,小修了2次(相当于这个审稿人审了3次文章),每次都是审10天左右,然后等编辑5天左右做决定,也就是一次修稿周期就得20天,今天终于接收了。9月18号投的稿。 送审之后修回的概率很大,对大而不精的综述特别友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/36e4b1345247d92b63b923885e50e463.jpg, createdBy=921d5250503, createdName=147ddcd3m55暂无昵称, createdTime=Fri Dec 15 01:05:53 CST 2023, time=2023-12-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192558, encodeId=95eb21925583c, content=记录一下,2月22日投稿,1600+,还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f7f5535320, createdName=ms3000000361924578, createdTime=Mon Mar 11 14:09:31 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2185510, encodeId=c458218551089, content=偏重的研究方向:心血管<br>经验分享:2023年12月8 Submitted<br>2024年1月15 with editor<br>2024年1月30 Under Review<br>还要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98188622439, createdName=ms3000001775227501, createdTime=Fri Feb 02 15:09:20 CST 2024, time=2024-02-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2193046, encodeId=494b21930461d, content=偏重的研究方向:肿瘤;综述<br>经验分享:为啥找不到审稿人呢<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4019047506, createdName=ms2000001254072347, createdTime=Wed Mar 13 20:37:05 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194188, encodeId=3695219418871, content=好像最近没有中国人的论著文章发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0ea8286723, createdName=ms3000000851999119, createdTime=Tue Mar 19 23:26:22 CST 2024, time=2024-03-19, status=1, ipAttribution=弗吉尼亚)]
    2024-03-11 ms3000000361924578 来自北京

    记录一下,2月22日投稿,1600+,还是submitted to journal

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2172039, encodeId=78e921e2039b3, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:基础article<br>经验分享:经常刷论坛看看大家的新进展,总想着接收了来分享自己的流程,每天刷新系统,终于等来了accept,流程具体时间记不清楚了,大致回忆下:<br>8月底投稿<br>20天后with editor<br>2天后under review<br>10月初开始陆续回来外审意见,邀请了9个审稿人,3个审稿人接受审稿,审稿意见那是一个真刁钻,都是送命题,要求大修,感觉部分审稿人就存在偏见,没办法,谁让他们是审稿人呢,只能按要求办了。<br>天天熬夜补实验,然后润色,1个多月后修回,编辑那里效率很高,当天就with editor,第二天再次送审<br>11天后accept<br>注:投稿的时候上传了所有原始数据,WB的图全是整膜,也上传了路线图,所以编辑那里过得快,没再补什么;感觉最近接收了好多综述,现在投稿的人太多了,14天很难处理得过来,后边的时间就会延长,送审了过后邮件会有链接追溯文章的状态,还可以用**订阅。接收后邮件里也有链接让确认,然后就是缴费,可以用支付宝、**直接支付,方便了很多,支付了再给Invoice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a52b5395228, createdName=ms3000001076220736, createdTime=Thu Nov 30 10:30:33 CST 2023, time=2023-11-30, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2195921, encodeId=139a219592122, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/0e14153e72354362b59e8a071c515255-bF5cocj4dNVm.png, type=image, width=781, height=315)], authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Thu Mar 28 19:40:17 CST 2024, time=2小时前, status=0, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2185142, encodeId=63162185142c0, content=多久有人愿意审稿呀。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Wed Jan 31 23:23:06 CST 2024, time=2024-01-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189500, encodeId=7ef62189500b2, content=偏重的研究方向:肿瘤<br>经验分享:年前投稿的,昨天送审,1000+号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4019047506, createdName=ms2000001254072347, createdTime=Mon Feb 26 19:11:05 CST 2024, time=2024-02-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192087, encodeId=2e7d219208ead, content=记录一下,2.16投稿的,1300+,今天还是Submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aa0b5490731, createdName=chy, createdTime=Fri Mar 08 14:54:38 CST 2024, time=2024-03-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2175017, encodeId=05c721e5017e2, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;综述<br>经验分享:66**号,第二次投稿(8月初第一次没找到审稿人,一个月拒了,说欢迎修改题目和关键词后重投),第二次投稿邀请了25个人,终于找到了一个审稿人愿意审稿,小修了2次(相当于这个审稿人审了3次文章),每次都是审10天左右,然后等编辑5天左右做决定,也就是一次修稿周期就得20天,今天终于接收了。9月18号投的稿。 送审之后修回的概率很大,对大而不精的综述特别友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/36e4b1345247d92b63b923885e50e463.jpg, createdBy=921d5250503, createdName=147ddcd3m55暂无昵称, createdTime=Fri Dec 15 01:05:53 CST 2023, time=2023-12-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192558, encodeId=95eb21925583c, content=记录一下,2月22日投稿,1600+,还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f7f5535320, createdName=ms3000000361924578, createdTime=Mon Mar 11 14:09:31 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2185510, encodeId=c458218551089, content=偏重的研究方向:心血管<br>经验分享:2023年12月8 Submitted<br>2024年1月15 with editor<br>2024年1月30 Under Review<br>还要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98188622439, createdName=ms3000001775227501, createdTime=Fri Feb 02 15:09:20 CST 2024, time=2024-02-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2193046, encodeId=494b21930461d, content=偏重的研究方向:肿瘤;综述<br>经验分享:为啥找不到审稿人呢<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4019047506, createdName=ms2000001254072347, createdTime=Wed Mar 13 20:37:05 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194188, encodeId=3695219418871, content=好像最近没有中国人的论著文章发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0ea8286723, createdName=ms3000000851999119, createdTime=Tue Mar 19 23:26:22 CST 2024, time=2024-03-19, status=1, ipAttribution=弗吉尼亚)]
    2024-02-02 ms3000001775227501 来自福建省

    偏重的研究方向:心血管
    经验分享:2023年12月8 Submitted
    2024年1月15 with editor
    2024年1月30 Under Review
    还要多久啊

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2172039, encodeId=78e921e2039b3, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:基础article<br>经验分享:经常刷论坛看看大家的新进展,总想着接收了来分享自己的流程,每天刷新系统,终于等来了accept,流程具体时间记不清楚了,大致回忆下:<br>8月底投稿<br>20天后with editor<br>2天后under review<br>10月初开始陆续回来外审意见,邀请了9个审稿人,3个审稿人接受审稿,审稿意见那是一个真刁钻,都是送命题,要求大修,感觉部分审稿人就存在偏见,没办法,谁让他们是审稿人呢,只能按要求办了。<br>天天熬夜补实验,然后润色,1个多月后修回,编辑那里效率很高,当天就with editor,第二天再次送审<br>11天后accept<br>注:投稿的时候上传了所有原始数据,WB的图全是整膜,也上传了路线图,所以编辑那里过得快,没再补什么;感觉最近接收了好多综述,现在投稿的人太多了,14天很难处理得过来,后边的时间就会延长,送审了过后邮件会有链接追溯文章的状态,还可以用**订阅。接收后邮件里也有链接让确认,然后就是缴费,可以用支付宝、**直接支付,方便了很多,支付了再给Invoice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a52b5395228, createdName=ms3000001076220736, createdTime=Thu Nov 30 10:30:33 CST 2023, time=2023-11-30, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2195921, encodeId=139a219592122, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/0e14153e72354362b59e8a071c515255-bF5cocj4dNVm.png, type=image, width=781, height=315)], authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Thu Mar 28 19:40:17 CST 2024, time=2小时前, status=0, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2185142, encodeId=63162185142c0, content=多久有人愿意审稿呀。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Wed Jan 31 23:23:06 CST 2024, time=2024-01-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189500, encodeId=7ef62189500b2, content=偏重的研究方向:肿瘤<br>经验分享:年前投稿的,昨天送审,1000+号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4019047506, createdName=ms2000001254072347, createdTime=Mon Feb 26 19:11:05 CST 2024, time=2024-02-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192087, encodeId=2e7d219208ead, content=记录一下,2.16投稿的,1300+,今天还是Submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aa0b5490731, createdName=chy, createdTime=Fri Mar 08 14:54:38 CST 2024, time=2024-03-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2175017, encodeId=05c721e5017e2, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;综述<br>经验分享:66**号,第二次投稿(8月初第一次没找到审稿人,一个月拒了,说欢迎修改题目和关键词后重投),第二次投稿邀请了25个人,终于找到了一个审稿人愿意审稿,小修了2次(相当于这个审稿人审了3次文章),每次都是审10天左右,然后等编辑5天左右做决定,也就是一次修稿周期就得20天,今天终于接收了。9月18号投的稿。 送审之后修回的概率很大,对大而不精的综述特别友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/36e4b1345247d92b63b923885e50e463.jpg, createdBy=921d5250503, createdName=147ddcd3m55暂无昵称, createdTime=Fri Dec 15 01:05:53 CST 2023, time=2023-12-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192558, encodeId=95eb21925583c, content=记录一下,2月22日投稿,1600+,还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f7f5535320, createdName=ms3000000361924578, createdTime=Mon Mar 11 14:09:31 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2185510, encodeId=c458218551089, content=偏重的研究方向:心血管<br>经验分享:2023年12月8 Submitted<br>2024年1月15 with editor<br>2024年1月30 Under Review<br>还要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98188622439, createdName=ms3000001775227501, createdTime=Fri Feb 02 15:09:20 CST 2024, time=2024-02-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2193046, encodeId=494b21930461d, content=偏重的研究方向:肿瘤;综述<br>经验分享:为啥找不到审稿人呢<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4019047506, createdName=ms2000001254072347, createdTime=Wed Mar 13 20:37:05 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194188, encodeId=3695219418871, content=好像最近没有中国人的论著文章发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0ea8286723, createdName=ms3000000851999119, createdTime=Tue Mar 19 23:26:22 CST 2024, time=2024-03-19, status=1, ipAttribution=弗吉尼亚)]
    2024-03-13 ms2000001254072347 来自四川省

    偏重的研究方向:肿瘤;综述
    经验分享:为啥找不到审稿人呢

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2172039, encodeId=78e921e2039b3, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:基础article<br>经验分享:经常刷论坛看看大家的新进展,总想着接收了来分享自己的流程,每天刷新系统,终于等来了accept,流程具体时间记不清楚了,大致回忆下:<br>8月底投稿<br>20天后with editor<br>2天后under review<br>10月初开始陆续回来外审意见,邀请了9个审稿人,3个审稿人接受审稿,审稿意见那是一个真刁钻,都是送命题,要求大修,感觉部分审稿人就存在偏见,没办法,谁让他们是审稿人呢,只能按要求办了。<br>天天熬夜补实验,然后润色,1个多月后修回,编辑那里效率很高,当天就with editor,第二天再次送审<br>11天后accept<br>注:投稿的时候上传了所有原始数据,WB的图全是整膜,也上传了路线图,所以编辑那里过得快,没再补什么;感觉最近接收了好多综述,现在投稿的人太多了,14天很难处理得过来,后边的时间就会延长,送审了过后邮件会有链接追溯文章的状态,还可以用**订阅。接收后邮件里也有链接让确认,然后就是缴费,可以用支付宝、**直接支付,方便了很多,支付了再给Invoice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a52b5395228, createdName=ms3000001076220736, createdTime=Thu Nov 30 10:30:33 CST 2023, time=2023-11-30, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2195921, encodeId=139a219592122, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/0e14153e72354362b59e8a071c515255-bF5cocj4dNVm.png, type=image, width=781, height=315)], authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Thu Mar 28 19:40:17 CST 2024, time=2小时前, status=0, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2185142, encodeId=63162185142c0, content=多久有人愿意审稿呀。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b46401167, createdName=ms8000001441772842, createdTime=Wed Jan 31 23:23:06 CST 2024, time=2024-01-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189500, encodeId=7ef62189500b2, content=偏重的研究方向:肿瘤<br>经验分享:年前投稿的,昨天送审,1000+号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4019047506, createdName=ms2000001254072347, createdTime=Mon Feb 26 19:11:05 CST 2024, time=2024-02-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192087, encodeId=2e7d219208ead, content=记录一下,2.16投稿的,1300+,今天还是Submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aa0b5490731, createdName=chy, createdTime=Fri Mar 08 14:54:38 CST 2024, time=2024-03-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2175017, encodeId=05c721e5017e2, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;综述<br>经验分享:66**号,第二次投稿(8月初第一次没找到审稿人,一个月拒了,说欢迎修改题目和关键词后重投),第二次投稿邀请了25个人,终于找到了一个审稿人愿意审稿,小修了2次(相当于这个审稿人审了3次文章),每次都是审10天左右,然后等编辑5天左右做决定,也就是一次修稿周期就得20天,今天终于接收了。9月18号投的稿。 送审之后修回的概率很大,对大而不精的综述特别友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/20/36e4b1345247d92b63b923885e50e463.jpg, createdBy=921d5250503, createdName=147ddcd3m55暂无昵称, createdTime=Fri Dec 15 01:05:53 CST 2023, time=2023-12-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192558, encodeId=95eb21925583c, content=记录一下,2月22日投稿,1600+,还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f7f5535320, createdName=ms3000000361924578, createdTime=Mon Mar 11 14:09:31 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2185510, encodeId=c458218551089, content=偏重的研究方向:心血管<br>经验分享:2023年12月8 Submitted<br>2024年1月15 with editor<br>2024年1月30 Under Review<br>还要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98188622439, createdName=ms3000001775227501, createdTime=Fri Feb 02 15:09:20 CST 2024, time=2024-02-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2193046, encodeId=494b21930461d, content=偏重的研究方向:肿瘤;综述<br>经验分享:为啥找不到审稿人呢<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4019047506, createdName=ms2000001254072347, createdTime=Wed Mar 13 20:37:05 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194188, encodeId=3695219418871, content=好像最近没有中国人的论著文章发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0ea8286723, createdName=ms3000000851999119, createdTime=Tue Mar 19 23:26:22 CST 2024, time=2024-03-19, status=1, ipAttribution=弗吉尼亚)]
    2024-03-19 ms3000000851999119 来自弗吉尼亚

    好像最近没有中国人的论著文章发表

    0

共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分